USPSTF Recommends High Blood Pressure Screening

Share this content:
USPSTF Recommends High Blood Pressure Screening
USPSTF Recommends High Blood Pressure Screening

TUESDAY, Oct. 13, 2015 (HealthDay News) -- The U.S. Preventive Services Task Force (USPSTF) recommends blood pressure screening for adults and use of confirmatory blood pressure measurement outside the clinic setting. These findings form the basis of a review and recommendation statement published online Oct. 12 in the Annals of Internal Medicine.

Daichi Shimbo, M.D., from the Columbia University Medical Center in New York City, and colleagues reviewed the evidence relating to blood pressure screening and the role of ambulatory and home blood pressure monitoring.

The researchers note that adults aged 18 to 39 years at average risk should be screened for high blood pressure every three to five years. Annual screening is recommended for adults aged 40 years and older or for those at increased risk. The USPSTF recommends that before treatment is started, measurements should be obtained outside a clinical setting. Ambulatory blood pressure monitoring should be considered a reference standard for confirming elevated blood pressure; less evidence supports the use of home blood pressure monitoring.

"Diagnosing high blood pressure, and treating it appropriately, is critical for reducing a patient's risk of strokes, heart attacks, and other adverse health outcomes," task force member Kirsten Bibbins-Domingo, Ph.D., M.D., said in a statement. "Confirmation with blood pressure measurement outside of the office is an important step to ensure that we are carefully and accurately diagnosing this condition."

Two of the review authors disclosed financial ties to the pharmaceutical industry.

Evidence Review
Recommendation Statement

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease


More in Home

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Insulin Glargine, Lixisenatide Combo Beneficial in T2DM

Improved achievement of glycemic targets, reduced body weight

European, American Guidelines Lead to Different Recs for Statins

European, American Guidelines Lead to Different Recs for ...

Quantification of CAC score can improve stratification for those at high, low risk for events

Hyperbaric O2 Therapy Effective in Maxillary Osteoradionecrosis

Hyperbaric O<sub>2</sub> Therapy Effective in Maxillary Osteoradionecrosis

Positive clinical outcome with HBOT for 85.7 percent of patients with maxillary bone osteoradionecrosis

is free, fast, and customized just for you!

Already a member?

Sign In Now »